These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 17914953

  • 1. Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa.
    Ichikawa T, Ota H, Sugiyama A, Maruta F, Ikezawa T, Hotta K, Ishihara K.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1800-5. PubMed ID: 17914953
    [Abstract] [Full Text] [Related]

  • 2. Gastroprotective mechanism of lafutidine, a novel anti-ulcer drug with histamine H2-receptor antagonistic activity.
    Onodera S, Shibata M, Tanaka M, Inaba N, Arai Y, Aoyama M, Lee B, Yamaura T.
    Arzneimittelforschung; 1999 Jun; 49(6):519-26. PubMed ID: 10417869
    [Abstract] [Full Text] [Related]

  • 3. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
    Kim N, Park SH, Seo GS, Lee SW, Kim JW, Lee KJ, Shin WC, Kim TN, Park MI, Park JJ, Hong SJ, Shim KN, Kim SW, Shin YW, Chang YW, Chun HJ, Lee OJ, Jeon WJ, Park CG, Cho CM, Park CH, Won SY, Lee GH, Park KS, Shin JE, Kim HU, Park JY, Chae HS, Song GA, Kim JG, Yoon BC, Seol S, Jung HC, Chung IS.
    Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
    [Abstract] [Full Text] [Related]

  • 4. Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury: a randomized, double-blinded, placebo controlled study.
    Kato M, Kamada G, Yamamoto K, Nishida U, Imai A, Yoshida T, Ono S, Nakagawa M, Nakagawa S, Shimizu Y, Asaka M.
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1631-5. PubMed ID: 20880171
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacological and therapeutic properties of lafutidine (stogar and protecadin), a novel histamine H2 receptor antagonist with gastroprotective activity].
    Tanaka M, Banba M, Joko A, Moriyama Y.
    Nihon Yakurigaku Zasshi; 2001 Jun; 117(6):377-86. PubMed ID: 11436515
    [Abstract] [Full Text] [Related]

  • 6. Lafutidine can improve the quality of gastric ulcer healing in humans: a randomized, controlled, multicenter trial.
    Higuchi K, Watanabe T, Tominaga K, Shiba M, Nakagawa K, Uno H, Kitada K, Satoh H, Chono S, Oshitani N, Fujiwara Y, Arakawa T.
    Inflammopharmacology; 2006 Dec; 14(5-6):226-30. PubMed ID: 17186182
    [Abstract] [Full Text] [Related]

  • 7. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
    Koike T, Ohara S, Sehine H, Kawamura M, Abe Y, Inomata Y, Iijima K, Imatani A, Shimosegawa T.
    Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089
    [Abstract] [Full Text] [Related]

  • 8. Effects of combination treatment with famotidine and methylmethionine sulfonium chloride on the mucus barrier of rat gastric mucosa.
    Ichikawa T, Ito Y, Saegusa Y, Iwai T, Goso Y, Ikezawa T, Ishihara K.
    J Gastroenterol Hepatol; 2009 Mar; 24(3):488-92. PubMed ID: 19175830
    [Abstract] [Full Text] [Related]

  • 9. Feasibility study of supportive care using lafutidine, a histamine H2 receptor antagonist, to prevent gastrointestinal toxicity during chemotherapy for gastric cancer.
    Namikawa T, Munekage E, Maeda H, Kitagawa H, Kobayashi M, Hanazaki K.
    Anticancer Res; 2014 Dec; 34(12):7297-301. PubMed ID: 25503163
    [Abstract] [Full Text] [Related]

  • 10. Reversal of the tolerance phenomenon by the intermittent administration of a histamine H2-receptor antagonist.
    Takahashi M, Katayama Y.
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1493-7. PubMed ID: 20796145
    [Abstract] [Full Text] [Related]

  • 11. Palliative effect of lafutidine on oral burning sensation.
    Toida M, Kato K, Makita H, Long NK, Takeda T, Hatakeyama D, Yamashita T, Shibata T.
    J Oral Pathol Med; 2009 Mar; 38(3):262-8. PubMed ID: 19175712
    [Abstract] [Full Text] [Related]

  • 12. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
    Amagase K, Ochi A, Sugihara T, Kato S, Takeuchi K.
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S111-8. PubMed ID: 20586851
    [Abstract] [Full Text] [Related]

  • 13. The histamine H2 receptor antagonist lafutidine in Japanese patients with non-erosive reflux disease.
    Inamori M, Iida H, Hosono K, Endo H, Sakamoto Y, Takahashi H, Koide T, Tokoro C, Goto A, Abe Y, Hiratsuka N, Nakajima A, Fujita M.
    Hepatogastroenterology; 2010 May; 57(104):1430-4. PubMed ID: 21443098
    [Abstract] [Full Text] [Related]

  • 14. [A case of paclitaxel-induced peripheral neuropathy successfully treated by H2-blocker, lafutidine].
    Matsumura T, Imamura H, Kishimoto T, Miyazaki Y, Fujii C, Fujino M, Yasui Y, Anami S, Sumita R, Takada N, Fujita Y, Furukawa H.
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1565-8. PubMed ID: 19755835
    [Abstract] [Full Text] [Related]

  • 15. Effect of lafutidine, a novel histamine H2-receptor antagonist, on monochloramine-induced gastric lesions in rats: role of capsaicin-sensitive sensory neurons.
    Umeda M, Fujita A, Nishiwaki H, Takeuchi K.
    J Gastroenterol Hepatol; 1999 Sep; 14(9):859-65. PubMed ID: 10535466
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of neutrophil activation by lafutidine, an H2-receptor antagonist, through enhancement of sensory neuron activation contributes to the reduction of stress-induced gastric mucosal injury in rats.
    Harada N, Okajima K.
    Dig Dis Sci; 2007 Feb; 52(2):469-77. PubMed ID: 17211693
    [Abstract] [Full Text] [Related]

  • 17. Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism.
    Nakano M, Kitano S, Nanri M, Kiniwa M.
    Eur J Pharmacol; 2011 May 11; 658(2-3):236-41. PubMed ID: 21349265
    [Abstract] [Full Text] [Related]

  • 18. Lafutidine inhibits Helicobacter pylori-induced interleukin-8 production in human gastric epithelial cells.
    Nozawa Y, Nishihara K, Akizawa Y, Orimoto N, Nakano M, Uji T, Ajioka H, Kanda A, Matsuura N, Kiniwa M.
    J Gastroenterol Hepatol; 2004 May 11; 19(5):506-11. PubMed ID: 15086593
    [Abstract] [Full Text] [Related]

  • 19. [Effect of lafutidine, a novel antiulcer agent, on healing and relapse of acetic acid-induced gastric ulcer in rats].
    Onodera S, Tanaka M, Aoyama M, Arai Y, Shibata M, Yamaura T, Ohnishi H.
    Nihon Yakurigaku Zasshi; 1998 Mar 11; 111(3):167-75. PubMed ID: 9583080
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic effect of lafutidine against the adverse reaction induced in rat stomach by repeated administration of 5-fluorouracil.
    Kotani T, Nakagiri A, Murashima Y, Takeuchi K.
    Inflammopharmacology; 2007 Oct 11; 15(5):203-8. PubMed ID: 17943252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.